Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still’s disease: when dosage matters in overcoming secondary therapy resistance

Macrophage activation syndrome (MAS) is a severe, potentially fatal complication of rheumatic diseases. This case demonstrates the significant challenges and therapeutic considerations in adult-onset Still’s disease (AOSD) complicated with MAS at initial presentation, which will be discussed. MAS in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajeganova, Sofia, De Becker, Ann, Schots, Rik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692351/
https://www.ncbi.nlm.nih.gov/pubmed/33281955
http://dx.doi.org/10.1177/1759720X20974858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692351/
https://www.ncbi.nlm.nih.gov/pubmed/33281955
http://dx.doi.org/10.1177/1759720X20974858

Ejemplares similares